Aromatase inhibition and breast cancer /
Saved in:
| Imprint: | New York : Marcel Dekker, c2001. |
|---|---|
| Description: | xiii, 309 p. : ill. (some col.) ; 24 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4384888 |
Table of Contents:
- Preface
- Contributors
- Part I. Plenary Lecture
- 1.. Aromatase Inhibition: The Outcome of 20 Years of Drug Development
- Part II. Advanced Breast Cancer
- 2.. Role of Hormonal Therapy and Chemotherapy in Advanced Breast Cancer: An Overview
- 3.. Place of Aromatase Inhibitors in the Endocrine Therapy of Breast Cancer
- 4.. Clinical Overview of Aromatase Inhibitors
- 5.. Who Benefits Most from Second-Line Treatment with Letrozole?
- Panel Discussion 1. Advanced Breast Cancer
- Part III. Early Breast Cancer/Chemoprevention
- 6.. Neoadjuvant Endocrine Therapy
- 7.. Adjuvant Endocrine Therapy
- Panel Discussion 2. Early Breast Cancer/Chemoprevention
- 8.. Health Economics Aspects of Endocrine Therapy
- Panel Discussion 3. Health Economics Aspects of Endocrine Therapy
- 9.. Chemoprevention with Aromatase Inhibitors
- Panel Discussion 4. Chemoprevention
- Part IV. New Directions for Aromatase Research
- 10.. Immunohistochemistry of Aromatase: A Recent New Development
- 11.. Molecular Epidemiology of Aromatase Expression in 1182 Primary Breast Cancers
- 12.. Induction and Suppression of Aromatase by Inhibitors
- 13.. Relevance of Animal Models to the Clinical Setting
- Panel Discussion 5. New Directions from Aromatase Research
- Part V. New Clinical Indications for Aromatase Therapy
- 14.. Aromatase Inhibitors as Therapy for Pubertal Gynecomastia
- Panel Discussion 6. Aromatase Inhibitors and Gynecomastia
- 15.. Aromatase Inhibition and Prostate Cancer
- Panel Discussion 7. Aromatase and Prostate Cancer
- 16.. Aromatase in Endometriosis: Biological and Clinical Application
- Panel Discussion 8. Endometrium: Treatment of Benign and Malignant Disease
- Index
